Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1860 participants.

Also called NCT06365502

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,860 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06365502
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06365502. Randomized; single masking; primary purpose treatment. Start 2024-04-16 (actual); primary completion 2027-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)
Condition
Acute Coronary Syndrome (ACS)
Intervention (Device)
Drug-coated balloon
Intervention (Drug)
Guideline-directed medical treatment
Lead sponsor
Harbin Medical University (class: other)
Collaborator
Shanghai Shenqi Medical Technology Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct06365502
Content hash
c467abd9b3fff37f197a1d0e68ff75664db51526acb169f46b92249f7a1e0108